In PDAC, tumor- and nerve-derived Sema3D reprogram macrophages indirectly via KRAS mutation-dependent adenosine diphosphate-ribosylation factor 6 (ARF6) signaling in tumor cells. Here, KRAS is linked to neoplasm.